These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28711714)

  • 21. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Submicron Emulsions and Their Applications in Oral Delivery.
    Mundada V; Patel M; Sawant K
    Crit Rev Ther Drug Carrier Syst; 2016; 33(3):265-308. PubMed ID: 27910752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilizing food matrix effects to enhance nutraceutical bioavailability: increase of curcumin bioaccessibility using excipient emulsions.
    Zou L; Liu W; Liu C; Xiao H; McClements DJ
    J Agric Food Chem; 2015 Feb; 63(7):2052-62. PubMed ID: 25639191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier.
    Kanzer J; Tho I; Flaten GE; Mägerlein M; Hölig P; Fricker G; Brandl M
    J Pharm Pharmacol; 2010 Nov; 62(11):1591-8. PubMed ID: 21039543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability.
    Gamal W; Fahmy RH; Mohamed MI
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1530-1538. PubMed ID: 28447878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emulsion forming drug delivery system for lipophilic drugs.
    Wadhwa J; Nair A; Kumria R
    Acta Pol Pharm; 2012; 69(2):179-91. PubMed ID: 22568032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.
    Kohli K; Chopra S; Dhar D; Arora S; Khar RK
    Drug Discov Today; 2010 Nov; 15(21-22):958-65. PubMed ID: 20727418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease.
    Dahan A; Markovic M; Epstein S; Cohen N; Zimmermann EM; Aponick A; Ben-Shabat S
    Eur J Pharm Sci; 2017 Oct; 108():78-85. PubMed ID: 28627471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alginate graft copolymers and alginate-co-excipient physical mixture in oral drug delivery.
    Wong TW
    J Pharm Pharmacol; 2011 Dec; 63(12):1497-512. PubMed ID: 22060280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
    Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
    Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen.
    Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
    J Pharm Sci; 2012 Oct; 101(10):3593-603. PubMed ID: 22786667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preparation and characterization of cucurbitacin B sodium deoxycholate/phospholipid-mixed oral fast dissolving film and antitumor activity study].
    Yu C; Xiao YZ; Xun PH; Dai L; Han J; Yuan HL
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(10):1799-804. PubMed ID: 25282885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of sodium bicarbonate as a pharmaceutical formulation excipient on the interaction of fluvastatin with membrane phospholipids.
    Larocque G; Arnold AA; Chartrand E; Mouget Y; Marcotte I
    Eur Biophys J; 2010 Nov; 39(12):1637-47. PubMed ID: 20798935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
    Cui F; Shi K; Zhang L; Tao A; Kawashima Y
    J Control Release; 2006 Aug; 114(2):242-50. PubMed ID: 16859800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
    Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
    Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different types, applications and limits of enabling excipients of pharmaceutical dosage forms.
    Palcsó B; Zelkó R
    Drug Discov Today Technol; 2018 Jul; 27():21-39. PubMed ID: 30103860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microscopic methods in analysis of submicron phospholipid dispersions.
    Płaczek M; Kosela M
    Acta Pharm; 2016 Mar; 66(1):1-22. PubMed ID: 26959541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saturated phosphatidylcholine as matrix former for oral extended release dosage forms.
    Kolbina M; Bodmeier R; Körber M
    Eur J Pharm Sci; 2017 Oct; 108():86-92. PubMed ID: 28716757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.